Bassam Janji

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Topics

Breast Cancer Cells

Top Venues

Molecular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, Santiago Parpal, Elisabetta Bartolini, Kris Van Moer, Simone Caroline Kleinendorst, Kristine Bilgrav Saether, Lionel Trésaugues, Camilla Silvander, Johan Lindström, Jodi Simeon, Mary Jane Timson, Hikmat Al-Hashimi, Bryan D Smith, Daniel L Flynn, Andrey Alexeyenko, Jenny Viklund, Martin Andersson, Jessica Martinsson, Katja Pokrovskaja Tamm, Angelo De Milito, Bassam Janji
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy. Molecular oncology 18 (8) (2024)
Yasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, Santiago Parpal, Elisabetta Bartolini, Kris Van Moer, Simone Caroline Kleinendorst, Kristine Bilgrav Saether, Lionel Trésaugues, Camilla Silvander, Johan Lindström, Jodi Simeon, Mary Jane Timson, Hikmat Al-Hashimi, Bryan D Smith, Daniel L Flynn, Andrey Alexeyenko, Jenny Viklund, Martin Andersson, Jessica Martinsson, Katja Pokrovskaja Tamm, Angelo De Milito, Bassam Janji
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy. Molecular oncology 18 (8) (2024)
Elisabetta Bartolini, Kris Van Moer, Bassam Janji
Improving STING agonist-based cancer therapy by inhibiting the autophagy-related protein VPS34. Oncoimmunology 13 (1) (2024)
Yasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, Santiago Parpal, Elisabetta Bartolini, Kris Van Moer, Simone Caroline Kleinendorst, Kristine Bilgrav Saether, Lionel Trésaugues, Camilla Silvander, Johan Lindström, Jodi Simeon, Mary Jane Timson, Hikmat Al-Hashimi, Bryan D Smith, Daniel L Flynn, Andrey Alexeyenko, Jenny Viklund, Martin Andersson, Jessica Martinsson, Katja Pokrovskaja Tamm, Angelo De Milito, Bassam Janji
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy. Molecular oncology (2024)
Yasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, Santiago Parpal, Elisabetta Bartolini, Kris Van Moer, Simone Caroline Kleinendorst, Kristine Bilgrav Saether, Lionel Trésaugues, Camilla Silvander, Johan Lindström, Jodi Simeon, Mary Jane Timson, Hikmat Al-Hashimi, Bryan D Smith, Daniel L Flynn, Andrey Alexeyenko, Jenny Viklund, Martin Andersson, Jessica Martinsson, Katja Pokrovskaja Tamm, Angelo De Milito, Bassam Janji
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy. Molecular oncology 18 (8) (2024)
Elisabetta Bartolini, Kris Van Moer, Bassam Janji
Improving STING agonist-based cancer therapy by inhibiting the autophagy-related protein VPS34. Oncoimmunology 13 (1) (2024)
Yasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, Santiago Parpal, Elisabetta Bartolini, Kris Van Moer, Simone Caroline Kleinendorst, Kristine Bilgrav Saether, Lionel Trésaugues, Camilla Silvander, Johan Lindström, Jodi Simeon, Mary Jane Timson, Hikmat Al-Hashimi, Bryan D Smith, Daniel L Flynn, Andrey Alexeyenko, Jenny Viklund, Martin Andersson, Jessica Martinsson, Katja Pokrovskaja Tamm, Angelo De Milito, Bassam Janji
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy. Molecular oncology 18 (8) (2024)
Alice Benoit, Guillaume Vogin, Caroline Duhem, Guy Berchem, Bassam Janji
Lighting Up the Fire in the Microenvironment of Cold Tumors: A Major Challenge to Improve Cancer Immunotherapy. Cells 12 (13) (2023)
Najla Santos Pacheco de Campos, Bruna Santos Souza, Giselle Correia Próspero da Silva, Victoria Alves Porto, Ghanbar Mahmoodi Chalbatani, Gabriela Lagreca, Bassam Janji, Eloah Rabello Suarez
Carbonic Anhydrase IX: A Renewed Target for Cancer Immunotherapy. Cancers 14 (6) (2022)
Nicole Kiweler, Catherine Delbrouck, Vitaly I Pozdeev, Laura Neises, Leticia Soriano-Baguet, Kim Eiden, Feng Xian, Mohaned Benzarti, Lara Haase, Eric Koncina, Maryse Schmoetten, Christian Jaeger, Muhammad Zaeem Noman, Alexei Vazquez, Bassam Janji, Gunnar Dittmar, Dirk Brenner, Elisabeth Letellier, Johannes Meiser
Mitochondria preserve an autarkic one-carbon cycle to confer growth-independent cancer cell migration and metastasis. Nature communications 13 (1) (2022)
Malina Xiao, Caroline Duhem, Anwar Chammout, Guy Berchem, Bassam Janji
CMTM6 and CMTM7: New leads for PD-L1 regulation in breast cancer cells undergoing EMT. Journal of cellular biochemistry 123 (6) (2022)
Meriem Hasmim, Guy Berchem, Bassam Janji
A role for EMT in CD73 regulation in breast cancer. Oncoimmunology 11 (1) (2022)
Delphine Sauvage, Manon Bosseler, Elodie Viry, Georgia Kanli, Anais Oudin, Guy Berchem, Olivier Keunen, Bassam Janji
The BET Protein Inhibitor JQ1 Decreases Hypoxia and Improves the Therapeutic Benefit of Anti-PD-1 in a High-Risk Neuroblastoma Mouse Model. Cells 11 (18) (2022)
Audrey Lequeux, Muhammad Zaeem Noman, Malina Xiao, Kris Van Moer, Meriem Hasmim, Alice Benoit, Manon Bosseler, Elodie Viry, Tsolere Arakelian, Guy Berchem, Salem Chouaib, Bassam Janji
Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy. Oncogene 40 (28) (2021)
Malina Xiao, Meriem Hasmim, Audrey Lequeux, Kris Van Moer, Tuan-Zea Tan, Christine Gilles, Brett G Hollier, Jean Paul Thiery, Guy Berchem, Bassam Janji, Muhammad Zaeem Noman
Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer. Cancers 13 (5) (2021)
Bassam Janji, Salem Chouaib
"Suffocating" tumors by blocking adaptation to hypoxia: a new headway in melanoma immunotherapy. Oncoimmunology 10 (1) (2021)
Andy Chevigné, Bassam Janji, Max Meyrath, Nathan Reynders, Giulia D'Uonnolo, Tomasz Uchański, Malina Xiao, Guy Berchem, Markus Ollert, Yong-Jun Kwon, Muhammad Zaeem Noman, Martyna Szpakowska
CXCL10 Is an Agonist of the CC Family Chemokine Scavenger Receptor ACKR2/D6. Cancers 13 (5) (2021)
Muhammad Zaeem Noman, Santiago Parpal, Kris Van Moer, Malina Xiao, Yasmin Yu, Jenny Viklund, Angelo De Milito, Meriem Hasmim, Martin Andersson, Ravi K Amaravadi, Jessica Martinsson, Guy Berchem, Bassam Janji
Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti-PD-1/PD-L1 immunotherapy. Science advances 6 (18) (2020)
Bassam Janji, Meriem Hasmim, Santiago Parpal, Angelo De Milito, Guy Berchem, Muhammad Zaeem Noman
Lighting up the fire in cold tumors to improve cancer immunotherapy by blocking the activity of the autophagy-related protein PIK3C3/VPS34. Autophagy 16 (11) (2020)
Céline Hoffmann, Xianqing Mao, Joshua Brown-Clay, Flora Moreau, Antoun Al Absi, Hannah Wurzer, Barbara Sousa, Fernando Schmitt, Guy Berchem, Bassam Janji, Clément Thomas
Hypoxia promotes breast cancer cell invasion through HIF-1α-mediated up-regulation of the invadopodial actin bundling protein CSRP2. Scientific reports 8 (1) (2018)
Meriem Hasmim, Bassam Janji, Mehdi Khaled, Muhammad Zaeem Noman, Fawzia Louache, Didier Bordereaux, Abdou Abderamane, Veronique Baud, Fathia Mami-Chouaib, Salem Chouaib
Cutting Edge: NANOG Activates Autophagy under Hypoxic Stress by Binding to BNIP3L Promoter. Journal of immunology (Baltimore, Md. : 1950) 198 (4) (2017)